Implementation of newborn screening for Krabbe disease: Population study and cutoff determination
Authors:
- Joseph J. OrsiniJOJoseph J. Orsini
- Mark A. MorrisseyMMMark A. Morrissey
- Laura N. SlavinLSLaura N. Slavin
- Matthew WojcikMWMatthew Wojcik
- Chad BiskiCBChad Biski
- Monica MartinMMMonica Martin
- Michele CagganaMCMichele Caggana
- 1 June 2009
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (9) , 877-884
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Development and Evaluation of Quality Control Dried Blood Spot Materials in Newborn Screening for Lysosomal Storage DisordersClinical Chemistry, 2009
- Multiplex Enzyme Assay Screening of Dried Blood Spots for Lysosomal Storage Disorders by Using Tandem Mass SpectrometryClinical Chemistry, 2008
- Newborn Screening for Pompe Disease by Measuring Acid α-Glucosidase Activity Using Tandem Mass SpectrometryClinical Chemistry, 2008
- Early Detection of Pompe Disease by Newborn Screening Is Feasible: Results From the Taiwan Screening ProgramPediatrics, 2008
- High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*The American Journal of Human Genetics, 2006
- Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's DiseaseNew England Journal of Medicine, 2005
- Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn ScreeningClinical Chemistry, 2004
- Generation of a Mouse with Low Galactocerebrosidase Activity by Gene Targeting: A New Model of Globoid Cell Leukodystrophy (Krabbe Disease)Molecular Genetics and Metabolism, 2001
- Krabbe Disease: Genetic Aspects and Progress toward TherapyMolecular Genetics and Metabolism, 2000
- Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-β-d-galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe diseaseClinica Chimica Acta, 1992